Baby Rhys was diagnosed with SMA at 6 months old and needed a life saving drug that cost $2.1 million. She was able to get Zolgensma in August of 2020 and has responded well to the treatment. Thankfully, much of the cost of this expensive drug was covered by insurance. Funds raised here will continue to go towards the many remaining costs for Rhys’s ongoing care including co-pays and deductibles, doctors visits, physical therapy, mobility equipment, ADA adjustments to the Devine’s home to accommodate and supports Rhys’s mobility, and to continue to spread awareness of SMA so that other babies receive diagnosis and treatment before it’s too late. Thank you for your support. Follow Rhys’s story and current updates on Instagram @RiseUpForRhys In May of 2019 while on vacation in Scotland, Rory and I found out we were pregnant (though I already knew - mother’s intuition kicks in early!)  Our baby girl was due on Christmas Day, and after a perfectly healthy pregnancy and 20 hours of labor, we welcomed her 3 weeks early on December 4, 2019 at 12:13pm. Even though I had sworn not to give my children confusing-to-pronounce Welsh names as my mother had done to me, we decided to name her Rhys (pronounced Reese). Overnight she made us a family, and even her fur brother Bruce was absolutely in love. (Jury is still out for Tony). <img src="https://d2g8igdw686xgo.cloudfront.net/48861260_1592283090539576_r.jpeg" alt="48861260_1592283090539576_r.jpeg" width="100%" media_type="3" /> Rhys had been a healthy baby, loving her baths, walks outside, and cuddles and kisses from her doggies. As Rhys approached 4 months, that mother’s intuition was nagging me - I noticed that she seemed to be falling behind on milestones other babies her age were hitting. She always struggled with tummy time, and wasn’t able to roll over or hold her head up for very long. At her 4 month check up, our pediatrician said she just had low muscle tone and recommended physical therapy. At her next check up at 6 months, the pediatrician immediately noted Rhys’ lack of progression and expressed concerns that she may have Spinal Muscular Atrophy, a genetic condition we had never heard of before.  A quick Google search, confirmed every parent’s greatest fear: "The number 1 genetic disease that kills most babies up to 2 years old." Appointments with Geneticists and Pediatric Neuro-muscular Specialists were set, blood and saliva tests ordered, and the waiting began. We hoped it was something else less severe, easier to treat, less devastating. ANYTHING but SMA. After 2 weeks, the longest 2 weeks of our lives, we received the heartbreaking diagnosis - Rhys has SMA Type 1, the most severe form of the disease. <img src="https://d2g8igdw686xgo.cloudfront.net/48861260_159228328576931_r.jpeg" alt="48861260_159228328576931_r.jpeg" width="100%" media_type="3" /> SMA is a terminal muscle degenerative disease, affecting eating, speaking, moving and even breathing. It results in muscle wasting where infants often die of respiratory failure ​before reaching the age of two. With SMA Type 1, each day means loss of specialized nerve cells, leading to muscle weakness and muscle cell death. It is so rare that just a few years ago, there was no treatment. Parents had to watch as their child was able to move less and less, becoming unable to eat and breath on their own. There is no cure for SMA, but in the last 2 years, two life changing treatments have become available. One treatment, SPINRAZA, works on the SMN2 gene, which is a less active copy of the SMN1 gene (the gene that is missing/non-functioning in a person with SMA). By boosting production of SMN2, SPINRAZA supports muscle development and provides a level of improvement. SPINRAZA is very expensive at $750K in the first year and $375K every year thereafter for life. In August of 2019, a new gene therapy, ZOLGENSMA was approved by the FDA. It replaces the missing/non-functioning SMN1 gene with a new functional copy. This medicine provides life changing improvement, some patients are even able to walk independently. Such a miracle drug comes at a cost, and ZOLGENSMA is the most expensive drug in the world at $2.1 million USD. <img src="https://d2g8igdw686xgo.cloudfront.net/48861260_1592283493455846_r.jpeg" alt="48861260_1592283493455846_r.jpeg" width="100%" media_type="3" /> Because SMA Type 1 is aggressive and degenerative, this is a race against time. With each day that passes, motor neurons in Rhys’ sweet little body are becoming inactive. All funds raised will go to Rhys’s medical care including gene therapy (out-of-pocket responsibility outside of insurance not known at this time), physical and occupational therapy, mobility and development equipment, etc. She has a lifetime ahead of her and will need continuous treatment for the best chance at a full life. In the case there are additional funds beyond Rhys’s needs, they will go to Cure SMA, an organization dedicated to raising awareness for this devastating disease.  Every child should have the best possible chance at life - please join us to surround our happy little girl in love and support. Rise Up for Rhys!!! Find more info and stay tuned to www.RiseUpForRhys.com for updates. Share and invite others to support Rhys #RiseUpForRhys <img src="https://d2g8igdw686xgo.cloudfront.net/48861260_1592283624744124_r.jpeg" alt="48861260_1592283624744124_r.jpeg" width="100%" media_type="3" />

Jaime Shannon

Anonymous

Takesha Hardaway

Kris Dolceamore

Kate Hall

vicki adey

Sarah Watkins

Pamela L Waagen

Claudia Young

Bryan VandenBosch

Kelly Bergin

Lisa Odaibo

Patricia Lavery

Michelle Gacusan

Shirley Dobbs

Rise Up for Rhys

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Rise Up for Rhys

Still $90,578 to go. Help us build momentum.